ELMMB logo
Facebook logo Twitter logo

3.1 Bronchodilators

3.1 Bronchodilators

      3.1.1 Adrenoreceptor agonists
  Selective beta2-agonists
               GREEN      Salbutamol 
                                 metered dose inhaler (MDI) 100micrograms/inhalation 
                                 breath-actuated inhaler 100 microgram/inhalation (Airomir Autohaler®)  
                                 breath actuated dry powder  inhaler 100mcg/inhalation (Easyhaler® Salbutamol )
                                 breath actuated dry powder inhaler 200mcg/inhalation (Easyhaler® Salbutamol )
                                 dry powder inhaler 200 microgram/blister (Ventolin Accuhaler®)  
                                 nebuliser solution 2.5mg/2.5ml, 5mg/2.5mL
                                 syrup 2mg/5mL
               RED           Salbutamol
                                  injection 500 microgram/mL
                                  solution for intravenous infusion 5mg/5mL
              GREEN       Terbutaline
                                 dry powder inhaler 500 microgram/inhalation (Bricanyl Turbohaler®)  
                                 nebules 5mg/2mL          
              Longer acting beta 2  - agonists
              Use regularly in addition to inhaled corticosteroids and inhaled bronchodilators for improved control as described in Step 3
              of BTS guidelines. Comparative costs for longer acting beta2 - adrenoceptor stimulants are indicated.
               Formoterol should only be used in accordance with national and local guidance on the management of asthma or COPD. 
               In asthma it should not be used as monotherapy, but be used alongside inhaled corticosteroids as per MHRA advice.
              Formoterol metered dose inhaler (MDI) presented as the brand Easyhaler® is the first line long acting beta-2 agonist of 
              choice within Peninne Lancashire.
              GREEN       Formoterol
                                 dry powder for inhaler 12 microgram/inhalation (Easyhaler Formoterol ®)
              GREEN       Formoterol 
                                 dry powder inhaler 6 microgram/metered inhalation (Oxis Turbohaler®)  
                                 dry powder inhaler 12 microgram/metered inhalation (Oxis Turbohaler®) 
              Second line option
              GREEN       Salmeterol 
                                 metered dose inhaler (MDI) 25 microgram/inhalation (Serevent®)
                                 dry powder inhaler 50 microgram/blister (Serevent Accuhaler®) 
              Third line option for patients with moderate COPD who are having difficulties with either compliance or the inhaler device.
              GREEN      Indacaterol  
                                dry powder hard capsule 150, 300 microgram (Onbrez Breezhaler®)
                                Note minimum inspiratory flow rate required 50L/min  
             Beclomethasone dipropionate/formoterol fumarate dihydrate/glycopyrronium bromide [Trimbow®]
             For maintenance treatment of asthma, in adults not adequately controlled with a maintenance combination of a 
             long-acting beta-2 agonist plus a medium dose of inhaled corticosteroid, and who had one or more exacerbations 
             (flare-ups) in the past year.
             GREEN restricted use Beclomethasone dipropionate/formoterol fumarate dihydrate/glycopyrronium bromide 87/5/9 pMDI  
       3.1.2 Antimuscarinic bronchdilators
               For relieving bronchoconstriction in COPD as an alternative to beta2 -agonists. Ipratropium is a short acting muscarinic  
               antagonist whilst Tiotropium is long acting. Tiotropium is an option at step 2 of the local guidelines in those patients with 
               persistent exacebations/breathlesness.
               GREEN      Ipratropium bromide 
                                 metered dose inhaler (MDI) 20micrograms/inhalation
                                 nebuliser solution 250micrograms/mL
              GREEN       Tiotropium inhaler (Braltus®  Zonda inhaler) 
                                 (Braltus 10 microgram per delivered dose inhalation powder, hard capsule) 
              Add on maintenance bronchodilator treatment to relieve symptoms in adult patients with chronic obstructive pulmonary 
              disease (COPD)
              Note:  Ipratropium should be discontinued when tiotropium is introduced.
              GREEN     Tiotropium Spiriva®  Respimat   ®
              N.B. Braltus is the preferred Tiotropium product.The Tiotropium Respimat is restricted for use in COPD patients to those who  
                      have poor manual dexterity and difficulty using the Handihaler®  
              Add on maintenance bronchodilator treatment in adult patients with Asthma who meet all of the following criteria:
                 >     persistent airflow limitation demonstrated by an FEV¹ <80% predicted and a ratio of FEV¹/FVC  <70% and
                 >     currently treated with the maintenance combination of inhaled corticosteroids (>800 micrograms budesonide/day or
                        equivalent*) and long acting ß² agonists and 
                 >     experienced one or more severe exacerbations in the previous year. 
              Second line ONLY where Tiotropium is not appropriate, not tolerated or there is difficulty using the device.  
              Glycopyrronium bromide inhaler is available in a new device which requires lower inspiratory rate and enables visual  
              GREEN      Glycopyrronium bromide, inhaler (Seebri Breezhaler®) 
              3rd line ONLY where Tiotropium is not tolerated or there is difficulty using the device. 
              GREEN      Aclidinium bromide, inhalation powder (Eklira Genuair®)
              3rd line option when Tiotropium is not tolerated or the device cannot be used effectively
              Long acting Antimuscarinic bronchodilators in combination with Long-Acting Beta² agonists (LAMA/LABA)
              GREEN     Tiotropium  and  olodaterol 
                                (Spiolto® Respimat 2.5 microgram/2.5 microgram, inhalation solution) 
              Spiolto® Respimat is indicated as a maintenance bronchodilator treatment to relieve symptoms in adult patients with  
              chronic obstructive pulmonary disease (COPD).
              GREEN    Glycopyrronium bromide 85mcg/Indacterol maleate 43mcg inhalation powder 
                              capsule device.  (Ultibro®Breezhaler dry powder inhaler)
              GREEN    Aclidinium  and fomoterol 
                              (Duaklir® Genuair 340 micrograms /12 micrograms inhalation powder)
               GREEN   Glycopyrronium bromide 9 µg equivalent to 7.2 µg of glycopyrronium, and 5 µg of formoterol fumarate 
                               dihydrate mdi 
                               (Bevespi Aerosphere mdi)
              Duaklir Genuair is indicated as a maintenance bronchodilator treatment to relieve symptoms in adult patients with chronic 
              obstructive pulmonary disease (COPD)    
               Bevespi Aerosphere  is indicated as a maintenance bronchodilator treatment to relieve symptoms in adult patients with 
               chronic obstructive pulmonary disease (COPD).
              Triple combination inhaler [ICS + LAMA + LABA]
              Trimbow® inhaler  - link to guideline
              First line use in Patient Group D, where patient requires Triple Therapy (LAMA+LABA+ICS) (single combination inhaler,   
              dose 2puffs bd).
              (Use reserved for patients who have failed to achieve or maintain an adequate response to an appropriate course of dual
              GREEN [restricted use]  
                             Beclomethasone 87mcg, formoterol fumarate 5mcg, glycopyrronium bromide 9mcg 
                             (Trimbow®pMDI)   (dose = 2 puffs twice daily)
              GREEN [restricted use]
                            Beclomethasone 87mcg, formoterol fumarate 5mcg, glycopyrronium bromide 9mcg
                            (Trimbow® NEXThaler)   (dose = 2 puffs twice daily)
             Trixeo Aerosphere 5mcg/7.2mcg/160mcg pressurised inhalation, suspension
             Maintenance treatment in adult patients with moderate to severe chronic obstructive pulmonary disease (COPD) who are
             not adequately treated by a combination of an inhaled corticosteroid and a long-acting beta2-agonist or combination of a 
             long-acting beta2-agonist and a long-acting muscarinic antagonist. 
             The intended place in therapy for the Trixeo Aeropshere is in line with the 2019 NICE Guidelines for the treatment of  
             patients with moderate to severe COPD for whom a MDI is considered clinically appropriate and who experience a severe
             exacerbation (requiring hospitalisation) or two moderate exacerbations within a year whilst receiving ICS/LABA or 
             GREEN RESTRICTED  5μg formoterol fumarate dihydrate, glycopyrronium bromide 9μg, equivalent to 7.2μg of 
                                                   glycopyrronium, and budesonide 160μg
                          Trixeo Aerosphere (dose = 2 puffs twice daily)
         3.1.3 Theophylline
              Used for reversible airways obstruction. Narrow margin between therapeutic and toxic dose.                      
              Prescribe oral preparations by brand name.

              GREEN      Theophylline (Uniphyllin®) tablets m/r 200mg, 300mg, 400 mg      
              Other preparations 
              AMBER     Aminophylline tablets 225mg, 350mg 
              RED           Aminophylline injection 25mg/ml, 10mL ampoule 
              RED           Caffeine citrate oral solution 50mg/5mL (unlicensed) 
              RED           Caffeine citrate intravenous injection 10mg/2mL (NICU only) (unlicensed) 
              Note: caffeine 10mg = caffeine citrate 20mg.
              To avoid confusion these preparations must always be prescribed as CAFFEINE CITRATE.
         3.1.4 Compound bronchodilator preparations
              In COPD, salbutamol alone should be used first line
              GREEN     Combivent® nebuliser solution - (ipratropium 500 microgram & salbutamol 2.5mg/ 2.5ml vial)
          3.1.5 Peak flow meters, inhaler devices and nebulisers
          Patients who require a spacer device for the first time with Allen & Hanbury inhalers (e.g. Ventolin® and Serevent® brands) 
          should be prescribed a Volumatic spacer device.  Aerochamber® is an alternative for other inhalers brands as it is less
          bulky and fits all MDIs.

          If you are prescribing any spacer device to a patient for the first time, these patients should be monitored frequently in the 
          normal way for the emergence of or worsening of symptoms of disease or adverse effects. Any patients who are switched
          to a different device should be regarded in the same way as new patients, and the same careful monitoring is required.
          For inhaled ß2 agonist bronchodilators the most frequent signs of toxicity are headache, tremor and palpitations;
          for inhaled corticosteroids the most serious concern from over exposure is adrenal suppression and particularly when high
          doses are administered to children and adolescents.

          GREEN      Nebuchamber® 
          GREEN      Volumatic® 
          GREEN      AeroChamber Plus® 
          GREEN      Space Chamber Plus®
          GREEN      Compact Space Chamber Plus®
          GREEN      AeroChamber® Plus Flow-Vu anti-static device
   back to main page

 All material in this section is aimed at health care professionals, but is information currently held in the public domain, members of the
 public seeking advice on medicine-related matters are advised to speak with their GP, pharmacist, nurse or contact NHS111 Service
 Email: info.elmmb@nhs.net
 Copyright© 2016 -2020 East Lancashire Medicines Management Board
 All rights reserved.  Disclaimer/Terms and conditions